Cite
MLA Citation
Michael Zhong et al.. “Prediction of multiple sclerosis outcomes when switching to ocrelizumab.” Multiple sclerosis, vol. 28, 2022, pp. 958–969. http://access.bl.uk/ark:/81055/vdc_100147707853.0x000024
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Michael Zhong et al.. “Prediction of multiple sclerosis outcomes when switching to ocrelizumab.” Multiple sclerosis, vol. 28, 2022, pp. 958–969. http://access.bl.uk/ark:/81055/vdc_100147707853.0x000024